AFFINITY DRUG DESIGN LIMITED

🌳Matureactive
08466627 · ltd · incorporated 2013-03-28
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
  • · Thesis: well-run, low negotiation leverage
🔒Estimated value
—
Upgrade to see
Turnover
—
year to Mar 2026
Net worth
£22.8k
book net assets
Opportunity
78/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

🔒Generate AI memo →🔒Outreach pack →🔒Corporate story →📑 Reports →Sign in to watch
What this business does
Primary activity: Other human health activities
Sector: Human health & social work
Investor take
Pursue
Asset-holding vehicle with a 68-year-old founder — textbook succession opportunity.

Opportunity 78/100 (strong), bankability 75/100. Strong seller-intent signal (68/100, director aged 68). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: high (80/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
2 officers (2 active, 2 linked, 2 with DOB)
90
Ownership & PSC
2 active PSC(s) of 2 total, 2 with control declared
90
Director network
2 connected companies via shared directors
51
Filing history
35 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
78/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Positive net assets
Net assets £22,832
Net assets shrinking
Down £8,408 YoY

Key financials

2 years extracted from filed iXBRL accounts
Cash
—
Net Worth
£23k
↓ 27% YoY
Current Assets
£24k
↓ 26% YoY
Current Liabilities
—
£0£6k£13k£19k£26k£32kMar 2025Mar 2026

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2026-03-312025-03-31
Total assets£22.8k£31.2k
Current assets£23.7k£32.1k
Net assets£22.8k£31.2k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
1
filing
  • • 1 accounts
Last 90 days
1
filing
  • • 1 accounts
Last 180 days
2
filings
  • • 1 accounts
  • • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (19 events)Click to expand
  1. 2026-06-22
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2025-06-25
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  3. 2024-07-19
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  4. 2023-07-17
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  5. 2023-05-02
    📄
    change-person-director-company-with-change-date
    officers · CH01
  6. 2023-05-02
    📄
    change-person-director-company-with-change-date
    officers · CH01
  7. 2022-12-22
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  8. 2022-08-09
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  9. 2021-10-06
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  10. 2020-10-12
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  11. 2019-10-29
    📄
    capital-name-of-class-of-shares
    capital · SH08
  12. 2019-09-11
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  13. 2018-09-25
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  14. 2018-04-16
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  15. 2018-04-16
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  16. 2018-04-05
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  17. 2013-03-28
    🏢
    Company incorporated
    As AFFINITY DRUG DESIGN LIMITED
  18. 2013-03-28
    ➕
    FINN, Angela appointed
    director
  19. 2013-03-28
    ➕
    FINN, Paul William appointed
    director

Owner dependency

86/100
Critical — business is the founder

The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Founder age: Director aged approximately 68 — succession pressure is live.
  • +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
  • +No director turnover: Company is 13 years old with no director changes — suggests a very tight-knit founder team never broadened.

Succession & seller-readiness

69/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 68. Approaching typical UK retirement age — succession thinking likely.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • secondary12+ year tenure: Director in role 13 years.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

2 active beneficial owners
NameSharesVoting rightsNature of controlNotified
Mr Paul William Finn
Individual · British · DOB 10/1958 · age 68
25–50%
—25-50% shares01/06/2016
Angela Finn
Individual · British · DOB 03/1961 · age 65
25–50%
—25-50% shares01/06/2016

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Healthcare & medical · OX postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
ABINGDON THERAPY AND MEDIATION SERVICE C.I.C.→
17113875 · est 2026 · no financials extracted
———————
ADIAN LOCUMS & CONSULTANTS LIMITED→
08307247 · est 2012 · no financials extracted
————13y——
ADOLCARE SERVICE LIMITED→
12182836 · est 2019 · no financials extracted
————6y——
ADVANCED COMMUNICATION SOLUTIONS LIMITED→
03189815 · est 1996 · no financials extracted
————29y——
ADVOCATE CARE SERVICES LTD→
09867619 · est 2015 · no financials extracted
————10y——
AESTHETICS BY ANGELA LTD→
13747629 · est 2021 · no financials extracted
————4y——
AFFINITY TRUST→
06893564 · est 2009 · no financials extracted
————16y——
AFTER THE CLOUDS FOUNDATION LIMITED→
08411806 · est 2013 · no financials extracted
————13y——
AGAMATRIX EUROPE LIMITED→
06410118 · est 2007 · no financials extracted
————18y——
AGAPE CARELINE LTD→
11156289 · est 2018 · no financials extracted
————8y——
AGNR MEDICS LIMITED→
10604904 · est 2017 · no financials extracted
————9y——
AHDB LIMITED→
08895542 · est 2014 · no financials extracted
————12y——
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2013-03-28
Jurisdictionengland-wales
Primary SIC86900 — Other human health activities

Registered office

6-7 Citibase, New Barclay House
234 Botley Road
Oxford
OX2 0HP
England

Filing status

Accounts
Next due: 2027-12-31
Last made up to: 2026-03-31
Confirmation statement
Next due: 2027-04-11
Last: 2026-03-28

Officers (2 active · 0 resigned)

FINN, Angela→
director · ~65y · appointed 2013-03-28
View their other companies + combined net worth →
Active
FINN, Paul William→
director · ~68y · appointed 2013-03-28
View their other companies + combined net worth →
Active

Click a director name to see their full track record across all companies.

Recent filings (35 total)

accounts-with-accounts-type-micro-entity
accounts · AA
2026-06-22
confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-04-10
accounts-with-accounts-type-micro-entity
accounts · AA
2025-06-25
confirmation-statement-with-no-updates
confirmation-statement · CS01
2025-05-06
accounts-with-accounts-type-micro-entity
accounts · AA
2024-07-19
confirmation-statement-with-no-updates
confirmation-statement · CS01
2024-04-12
accounts-with-accounts-type-micro-entity
accounts · AA
2023-07-17
confirmation-statement-with-no-updates
confirmation-statement · CS01
2023-05-02
change-person-director-company-with-change-date
officers · CH01
2023-05-02
change-person-director-company-with-change-date
officers · CH01
2023-05-02
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2022-12-22
accounts-with-accounts-type-micro-entity
accounts · AA
2022-08-09
confirmation-statement-with-no-updates
confirmation-statement · CS01
2022-03-28
accounts-with-accounts-type-micro-entity
accounts · AA
2021-10-06
confirmation-statement-with-no-updates
confirmation-statement · CS01
2021-04-07